Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03534726 · ClinicalTrials.gov registry record

Edema and Fibrosis CMR Imaging in Cardiomyopathy

A clinical trial of Cardiomyopathies, sponsored by University of Pennsylvania.

Active
Registry status
13
Enrollment target
1
Study location

NCT03534726: Active study of Cardiomyopathies, sponsored by University of Pennsylvania.

NCT03534726 is a study of Cardiomyopathies that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 13 participants, below the 635-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03534726, a study of Cardiomyopathies, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
13 participants
Enrollment target
1
Study location

Study Summary

7 Tesla MRI is a new magnetic field strength that has become available at Penn for cardiovascular MRI. This new scanner has potential to improve assessment of cardiovascular disease due to its increased signal-to-noise ratio, higher spatial resolution, and response to magnetic properties of tissue at high field. The purpose of this study is to assess the feasibility of 7 T CMR. Secondly, we wish to investigate its use, to improve clinical and research MRI. Altogether, 7 T may permit better clinical diagnosis of cardiomyopathy.

Conditions Studied

Cardiomyopathies

Interventions

  • DEVICE 7 T CMR

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2018-02-01
Est. Completion 2027-12-31
University of Pennsylvania

1,423 total trials

What the registry record for NCT03534726 still lists

NCT03534726 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 635-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cardiomyopathies appearing as the primary indexed condition, and to 1 intervention - of which 7 T CMR is the first listed.

NCT03534726 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03534726 about?

NCT03534726 is a clinical study titled "Edema and Fibrosis CMR Imaging in Cardiomyopathy". 7 Tesla MRI is a new magnetic field strength that has become available at Penn for cardiovascular MRI. This new scanner has potential to improve assessment of cardiovascular disease due to its increased signal-to-noise ratio, higher spatial resolution, and response to magnetic properties of tissue a...

What is the current status of trial NCT03534726?

This trial is currently active not recruiting. The enrollment target is 13 participants. The study started on 2018-02-01. Estimated completion is 2027-12-31.

What conditions does trial NCT03534726 study?

This clinical trial studies the following conditions: Cardiomyopathies.

What interventions are being tested in trial NCT03534726?

The interventions under investigation include: 7 T CMR (DEVICE).

Who is sponsoring clinical trial NCT03534726?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03534726 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiomyopathies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03534726's enrollment target sits among peer trials

13 18th of 17 the lowest of 17 other Cardiomyopathies trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiomyopathies trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT03534726, the US trial registry maintained by the National Library of Medicine. NCT03534726 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.